SIC
CLB icon

Schwartz Investment Counsel’s Core Laboratories CLB Stock Holding History

Schwartz Investment Counsel’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-204,100
Closed -$4.9M – 139
2023
Q3 		$4.9M Hold
204,100
– – 0.21% 77
2023
Q2 		$4.75M Sell
204,100
-114,000
-36% -$2.58M 0.2% 78
2023
Q1 		$7.01M Hold
318,100
– – 0.31% 72
2022
Q4 		$6.45M Sell
318,100
-50,000
-14% -$969K 0.29% 68
2022
Q3 		$4.96M Buy
368,100
+204,000
+124% +$3.44M 0.25% 72
2022
Q2 		$3.25M Buy
164,100
+70,000
+74% +$1.86M 0.16% 78
2022
Q1 		$2.98M Buy
+94,100
New +$2.64M 0.13% 81

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Schwartz Investment Counsel's CLB Position: Q4 2023 in Review

Schwartz Investment Counsel sold out of Core Laboratories (CLB) in Q4 2023, closing a stake of 204,100 shares — an estimated $4.9M sold.

Schwartz Investment Counsel first reported a position in CLB in Q1 2022 and held it in 7 quarters. The position peaked at $7.01M in Q1 2023. 186 funds tracked by Wall St. Rank hold CLB as of Q4 2023.

  • Schwartz Investment Counsel reported no remaining Core Laboratories position as of Q4 2023 after selling out during the quarter.
  • Schwartz Investment Counsel sold 204,100 Core Laboratories shares in Q4 2023, an estimated $4.9M.
  • Schwartz Investment Counsel first reported a position in Core Laboratories in Q1 2022 and held it in 7 quarters.
  • Schwartz Investment Counsel's Core Laboratories position peaked at $7.01M in Q1 2023.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2023.

Based on Schwartz Investment Counsel's 13F filing for Q4 2023, filed 26 Jan 2024.